Patent · US Active

Tetrazole compounds which selectively modulate the CB2 receptor

US8329735B2 · kind B2 · utility

24Cited by

40References

11Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Monika Ermann · Wantage, GB
Doris Riether · Biberach an der Riß, DE
Renee M. Zindell · New Milford, US

Key dates

Filing date	Mar 1, 2011
Grant date	Dec 11, 2012
Priority date	—
Expiry date	Mar 1, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D257/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of formula (I)are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.